Breast Cancer

Oral anticancer therapy is available to treat different types of cancer and metastatic disease.

Robin Roberts, who was one of the most influential people in cancer last year, returns to "Good Morning America" today after recovering from MDS and a bone marrow transplantation.

While breast cancer in young women appears to have similar characteristics, many experts agree that treating the type of breast cancer is more important than focusing on age at this point.

Cancer research updates from the San Antonio Breast Cancer Symposium and American Society of Hematology.

Guessing Game: Patients with metastatic cancer live with uncertainty.

With new research and legislation, women are learning what dense breast tissue means for breast cancer screening and risk.

The latest in cancer prevention, diagnosis & treatment.

Patients whose breast cancers are estrogen-positive have a wide variety of treatments available.

Neoadjuvant breast cancer therapy may be beneficial.

Advances in ostomy care and maintenance have resulted in more normal lives following colorectal cancer surgery.

New therapies and combinations make progress in HER2-positive breast cancer.

Research into vaccine therapy for cancer is extending to many cancer types.

The latest in cancer prevention, diagnosis & treatment.

Estrogen-only hormone therapy ups breast cancer risk if taken long term.

Only about a third of women undergo immediate breast reconstruction after mastectomy, according to a 2011 analysis in the Annals of Surgical Oncology, with 11.5 percent delaying reconstructive surgery for months or years, and more than half of patients foregoing it altogether.

For some survivors, genetic counseling could be a lifelong relationship.

Massage after breast cancer treatment can help ease many side effects.

New studies show radiation and chemotherapy may cause thinking problems that persist after treatment.

Regorafenib shows to extend survival in metastatic colorectal cancer.

Research updates from the annual San Antonio Breast Cancer Symposium and American Society of Hematology.

A new study published in The Lancet shows that one group could reduce their risk of colorectal cancer from taking the pill on a daily basis.

Afinitor (exemestane) and an aromatase inhibitor delay cancer growth in metastatic breast cancer.

A phase 3 randomized trial of two hormone therapies showed that in some postmenopausal women with hormone-positive metastatic breast cancer, the combo improves survival.

Women receiving a supportive care drug to reduce bone loss caused by breast cancer treatment may actually be getting more than that—improved survival and lower risk of metastatic recurrence.